to maximize the price obtained from a buyer is the stated objective now of Pwc in this bid process for the BioAmber buyout. With several companies that have been salivating all over this fairly new plant for some time now, it may not come to a surprise if all those who calculated getting $1 in equity residual from a bid war were right.
News 
Market Data 
Discover 
AI
